French intergroup guideline for gastric and gastroesophageal junction adenocarcinoma recommends perioperative FLOT for ≥cT2 and/or cN+ disease and platinum-fluoropyrimidine first line for metastatic disease, adding targeted or immunotherapy by biomarker.
Guideline
Zaanan et al. Gastric cancer: French intergroup clinical practice guidelines for diagnosis, staging, treatment and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACHBPT, RENAPE, SNFCP)